Epinephrine Injector
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-26-R-0009
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents4
The Defense Logistics Agency (DLA Troop Support), a federal office under the Department of Defense, has issued a solicitation (Procurement Identifier: SPE2D2-26-R-0009) for the establishment of a national requirements contract for Epinephrine Injectors. This procurement seeks to secure a reliable supply of Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S, packaged in 2-count bottles, to meet the needs of various federal agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will serve as a national supply source, facilitating purchases through the DLA and VA prime vendor programs.
The scope of this solicitation encompasses the provision of commercial pharmaceutical products, specifically epinephrine auto-injectors, which are critical for emergency treatment of severe allergic reactions. The acquisition is fully competitive and unrestricted, inviting proposals from all qualified sources. The contract will be structured as a firm-fixed price, requirements type agreement, featuring a one-year base period with four additional one-year option periods. This arrangement is designed to ensure consistent and flexible supply over a potential five-year lifecycle, with annual usage estimates detailed in the Schedule of Supplies section of the solicitation.
Procurement will be conducted in accordance with FAR Part 12, governing commercial item acquisitions, and FAR 52.216-21 (Requirements), which outlines the obligations for requirements contracts. The solicitation is classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505, indicating its focus on pharmaceutical products. There are no set-aside requirements or special restrictions, making this opportunity accessible to all capable manufacturers and suppliers.
Interested parties can access the solicitation documents and attachments via the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and on SAM.gov at https://sam.gov. The solicitation is currently active, with a posting date of April 11, 2026, and a response deadline of November 30, 2026. Contractors are encouraged to set up automated notifications for updates or changes to the solicitation.
For further information or inquiries, the primary point of contact is Jeremy Brown ([email protected], 445-737-5419), with Jason Wray ([email protected], 445-737-6304) as the secondary contact. The solicitation includes four attachments, which may provide additional details relevant to the opportunity.
This procurement represents a significant opportunity for pharmaceutical manufacturers and suppliers specializing in epinephrine auto-injectors to support critical federal healthcare and emergency response needs. The contract’s structure, scope, and competitive nature make it suitable for organizations with established capabilities in pharmaceutical preparation and distribution, seeking to partner with the federal government for long-term supply solutions.